Earnings Feed
Start Free
Home/Insiders/Epstein David R
ED
SEC Insider//CIK 0001445826

Epstein David R

CIK 00014458269 companiesANTWERPEN
SEC Profile

Transactions

50

Companies

9

Filings

14

CIK

0001445826

Recent Transactions

50 trades
  • Sale
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2026-02-02$59.41/sh−370→ 26,051 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Comnmon Stock

    2025-12-01$75.55/sh−250→ 26,421 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2025-11-03$90.00/sh−370→ 26,671 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Comnmon Stock

    2025-09-02$73.64/sh−250→ 27,041 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Comnmon Stock

    2025-08-01$55.16/sh−370→ 27,291 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Comnmon Stock

    2025-06-02$55.20/sh−250→ 27,661 total
  • Award
    Tempus AI, Inc.$TEM

    Class A Comnmon Stock

    2025-05-20+1,997→ 27,911 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2025-05-01$53.50/sh−370→ 25,914 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2025-03-17$46.83/sh−990→ 26,284 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2025-03-03$57.52/sh−250→ 27,274 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2025-02-03$53.31/sh−370→ 27,524 total
  • Sale
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2024-12-11$41.81/sh−620→ 27,894 total
  • Award
    Tempus AI, Inc.$TEM

    Class A Common Stock

    2024-06-13+28,514→ 28,514 total
  • Disposition to Issuer
    Seagen Inc.

    Common Stock

    2023-12-14$229.00/sh−16,407→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Performance Stock Units

    2023-12-14−2,644→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Stock Options (Right to Buy)

    2023-12-14−240,451→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Restricted Stock Units

    2023-12-14−39,650→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Performance Stock Units

    2023-12-14−5,286→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Stock Options (Right to Buy)

    2023-12-14−224,000→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Performance Stock Units

    2023-12-14−3,965→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Performance Stock Units

    2023-12-14−6,608→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Restricted Stock Units

    2023-12-14−80,541→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Stock Options (Right to Buy)

    2023-12-14−2,896→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Performance Stock Units

    2023-12-14−7,930→ 0 total
  • Disposition to Issuer
    Seagen Inc.

    Performance Stock Units

    2023-12-14−13,217→ 0 total
  • Sale
    Seagen Inc.

    Common Stock

    2023-11-10$213.01/sh−10,620→ 136,598 total
  • Award
    Seagen Inc.

    Common Stock

    2023-08-15+39,650→ 147,218 total
  • Award
    Seagen Inc.

    Common Stock

    2022-11-09+107,389→ 107,389 total
  • Award
    Seagen Inc.

    Non-Qualified Stock Option (Right to Buy)

    2022-11-09+400,000→ 400,000 total
  • Award
    Seagen Inc.

    Non-Qualified Stock Option (Right to Buy)

    2022-11-09+240,451→ 240,451 total
  • Award
    Seagen Inc.

    Incentive Stock Option (Right to Buy)

    2022-11-09+2,896→ 2,896 total
  • Award
    Senti Biosciences, Inc.$SNTI

    Stock Option (Right to Buy)

    2022-07-13+125,000→ 125,000 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Restricted Stock Units

    2022-06-30−2,053→ 0 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Common Stock

    2022-06-30+2,874→ 93,932 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Common Stock

    2022-06-30+2,053→ 91,058 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Restricted Stock Units

    2022-06-30−2,874→ 0 total
  • Award
    Evelo Biosciences, Inc.

    Stock Option (Right to Buy)

    2022-06-10+20,000→ 20,000 total
  • Exercise/Conversion
    Senti Biosciences, Inc.$SNTI

    Class B Common Stock

    2022-06-08−112,519→ 0 total
  • Award
    Senti Biosciences, Inc.$SNTI

    Common Stock

    2022-06-08+112,519→ 123,252 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Common Stock

    2022-05-31+2,052→ 86,132 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Restricted Stock Units

    2022-05-31−2,873→ 2,874 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Restricted Stock Units

    2022-05-31−2,052→ 2,053 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Common Stock

    2022-05-31+2,873→ 89,005 total
  • Purchase
    Evelo Biosciences, Inc.

    Common Stock

    2022-05-27$1.46/sh+17,123→ 84,080 total
  • Award
    Axcella Health Inc.

    Common Stock

    2022-05-19+47,059→ 209,756 total
  • Award
    Rubius Therapeutics, Inc.

    Stock Option (Right to Buy)

    2022-05-12+499,762→ 499,762 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Common Stock

    2022-05-02+2,873→ 66,957 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Common Stock

    2022-05-02+2,053→ 64,084 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Restricted Stock Units

    2022-05-02−2,053→ 4,105 total
  • Exercise/Conversion
    Evelo Biosciences, Inc.

    Restricted Stock Units

    2022-05-02−2,873→ 5,747 total

Companies

9

Recent Filings

14

Address

AGOMAB THERAPEUTICS NV POSTHOFLEI 1/6

ANTWERPEN, 2600

View on SEC.gov